Evidence map›Paper›PMID 42241447›Full record

ArticlePloS one2026

Tuberculosis in households with infectious cases in Kampala city: Harnessing health data science for new insights on an ancient disease with persistent, unresolved problems.

Emmanuel Nasinghe, Denis Musinguzi, Mercy Takuwa, Rogers Kamulegeya, Rose Nabatanzi, Sharon Namiiro, Cosmas Mwikirize, Andrew Katumba, Willy Ssengooba, Florence Nameere Kivunike and 2 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Emmanuel NasingheDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.
Denis MusinguziDepartment of Computer Science, College of Computing and Information Sciences, Makerere University (CoCIS), Kampala, Uganda.
Mercy TakuwaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.
Rogers KamulegeyaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.
Rose NabatanziDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.
Sharon NamiiroMakerere University Lung Institute (MLI), Kampala, Uganda.
Cosmas MwikirizeScience, Technology, Innovation, Office of the President, Kampala, Uganda.
Andrew KatumbaDepartment of Electrical and Computer Engineering, College of Engineering, Art and Design, Makerere University (CEDAT), Kampala, Uganda.
Willy SsengoobaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.ORCID https://orcid.org/0000-0002-1643-110X
Florence Nameere KivunikeDepartment of Information Technology, College of Computing and Information Sciences, Makerere University (CoCIS), Kampala, Uganda.ORCID https://orcid.org/0000-0001-6305-5242
Joyce Nakatumba-NabendeDepartment of Computer Science, College of Computing and Information Sciences, Makerere University (CoCIS), Kampala, Uganda.
David Patrick KateeteDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences (CHS), Kampala, Uganda.ORCID https://orcid.org/0000-0001-8075-3069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is prevalent in Uganda and overlaps with a high rate of HIV/TB coinfection. While nearly all hospital-based TB cases in Kampala, the capital of Uganda, show clear TB symptoms, 30% or more of undiagnosed TB cases found through active screening are asymptomatic. Additionally, the host risk factors for TB in Kampala cannot be distinguished from environmental risk factors. These TB-specific challenges are just part of the complexity, especially in areas with high HIV/AIDS burden. Data science techniques, especially Artificial Intelligence (AI) and Machine Learning (ML) algorithms, could help untangle this complexity by identifying factors related to the host, pathogen, and environment, which are difficult to explain or predict with traditional/conventional methods. In this project, we will use health data science approaches (AI/ML) to identify factors driving TB transmission within households and reasons for anti-TB treatment failure. We will utilize the computational resources at Makerere University and available demographic, clinical, and laboratory data from TB patients and their contacts to develop AI and ML algorithms. These will aim to: (1) identify patients at baseline (month 0) unlikely to convert their sputum or culture results by months 2 and 5, thus at risk of failing TB treatment; (2) identify household contacts of TB cases who are at risk of developing TB disease, as well as contacts who may resist TB infection despite repeated exposure to M. tuberculosis. Achieving these objectives will provide evidence that data science methods are effective for early detection of potential TB cases and high-risk patients, thereby helping to reduce TB transmission in the community. The study protocol received approval from the School of Biomedical Sciences IRB, protocol number SBS-2023-495.

Indexed as

Data ScienceTuberculosisAlgorithmsArtificial IntelligenceCoinfectionFamily CharacteristicsHIV InfectionsHumansMachine LearningRisk FactorsUganda

Identifiers

PMID42241447
PMCPMC13235878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.